Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression

Am J Psychiatry. 2000 Jan;157(1):124-6. doi: 10.1176/ajp.157.1.124.

Abstract

Objective: This study's purpose was to clarify the appropriate treatment of bipolar depression by comparing the addition of an antidepressant versus a second mood stabilizer for inpatients being treated with lithium carbonate or divalproex sodium.

Method: Twenty-seven patients were randomly assigned to groups that received double-blind treatment with paroxetine or a second mood stabilizer (lithium carbonate or divalproex sodium) for 6 weeks.

Results: Both groups showed significant improvement in depressive symptoms during the 6-week trial. There were significantly more noncompleters in the group being treated with the two mood stabilizers than in the group being treated with a mood stabilizer and paroxetine.

Conclusions: Both treatments appeared to be effective; however, the addition of an antidepressant may have greater clinical utility in the treatment of bipolar depression.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Antimanic Agents / therapeutic use*
  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / psychology
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Lithium Chloride / therapeutic use*
  • Male
  • Paroxetine / therapeutic use*
  • Patient Dropouts
  • Psychiatric Status Rating Scales / statistics & numerical data
  • Treatment Outcome
  • Valproic Acid / therapeutic use*

Substances

  • Antidepressive Agents, Second-Generation
  • Antimanic Agents
  • Paroxetine
  • Valproic Acid
  • Lithium Chloride